Astera Labs, Inc. (NASDAQ:ALAB) Receives $233.75 Consensus Price Target from Analysts

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-three ratings firms that are currently covering the company, Marketbeat reports. Eleven analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $233.75.

A number of analysts have recently commented on the company. Susquehanna boosted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Needham & Company LLC lifted their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Morgan Stanley boosted their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Finally, TD Cowen boosted their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $363.54 on Friday. The business’s fifty day moving average price is $204.28 and its two-hundred day moving average price is $169.07. The company has a market capitalization of $62.31 billion, a P/E ratio of 245.64, a PEG ratio of 4.71 and a beta of 3.95. Astera Labs has a 1-year low of $84.78 and a 1-year high of $372.37.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs will post 1.84 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This represents a 0.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,298,757 shares of company stock valued at $472,787,436 over the last quarter. Insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Assetmark Inc. increased its stake in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Reflection Asset Management bought a new stake in Astera Labs during the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank lifted its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new position in Astera Labs during the 4th quarter worth $33,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.